Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 11, 2015, Pages 2069-2079

  Werner, R N ^a   Stockfleth, E ^a,s   Connolly, S M ^b   Correia, O ^c   Erdmann, R ^a   Foley, P ^d,e,f   Gupta, A K ^g,h   Jacobs, A ^a   Kerl, H ⁱ   Lim, H W ^j   Martin, G ^k   Paquet, M ^h   Pariser, D M ^l   Rosumeck, S ^a   Rowert Huber H J ^a   Sahota, A ^m   Sangueza, O P ⁿ   Shumack, S ^o   Sporbeck, B ^a   Swanson, N A ^p,q   Torezan, L ^r   Nast, A ^a   more..

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAYO CLINIC   (United States)

^c University of Porto   (Portugal)

^d SKIN AND CANCER FOUNDATION   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g UNIVERSITY OF TORONTO   (Canada)

^h MEDIPROBE RESEARCH INC   (Canada)

ⁱ MEDICAL UNIVERSITY OF GRAZ   (Austria)

^j HENRY FORD HOSPITAL   (United States)

^k Dermatology Laser Center of Maui   (United States)

^l EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^m WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

ⁿ WAKE FOREST BAPTIST HEALTH   (United States)

^o UNIVERSITY OF SYDNEY   (Australia)

^p OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^q OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^r UNIVERSITY OF SÃO PAULO   (Brazil)

^s ST JOSEF HOSPITAL   (Germany)

more..

Author keywords

actinic keratosis; evidence based medicine; guideline; international guideline; practice guideline; recommendations; solar keratosis; squamous cell carcinoma; treatment

Indexed keywords

SUNSCREEN;

ACTINIC KERATOSIS; ALGORITHM; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); CONSENSUS; CRYOTHERAPY; EVIDENCE BASED PRACTICE; HISTORY; HUMAN; KERATINOCYTE; MEDICAL SOCIETY; METHODOLOGY; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); CONSENSUS DEVELOPMENT; EVIDENCE BASED MEDICINE; KERATOSIS, ACTINIC; MULTIMODALITY CANCER THERAPY;

COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; KERATOSIS, ACTINIC;

EID: 84945262614     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13180     Document Type: Review

References (48)

1. World Health Organization-Guidelines Review Committee. WHO handbook for guideline development. [WWW document] 2012. URL http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441-eng.pdf (last accessed: 16 January 2014).
2. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al,. Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490.
3. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al,. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011; 64: 383-394.
4. AGREE Next Steps Consortium. The AGREE II instrument. [WWW document] 2009. URL http://www.agreetrust.org (last accessed: 16 January 2014).
5. Higgins JPT, Green S,. Cochrane handbook for systematic reviews of interventions, version 5.1.0. [WWW document]. The Cochrane Collaboration, 2011. URL www.cochrane-handbook.org (last accessed: 5 January 2014).
6. Moher D, Liberati A, Tetzlaff J, Altman DG,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.
7. Jones J, Hunter D,. Consensus methods for medical and health services research. BMJ 1995; 311: 376-380.
8. Heaphy MR Jr, Ackerman AB,. The nature of solar keratosis: a critical review in historical perspective. J Am Acad Dermatol 2000; 43 (1 Pt 1): 138-150.
9. Rowert-Huber J, Patel MJ, Forschner T, Ulrich C, Eberle J, Kerl H, et al,. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol 2007; 156 (Suppl. 3): 8-12.
10. Ackerman AB, Mones JM,. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol 2006; 155: 9-22.
11. Cockerell CJ,. Histopathology of incipient intraepidermal squamous cell carcinoma ('actinic keratosis'). J Am Acad Dermatol 2000; 42 (1 Pt 2): 11-17.
12. Harvey I, Frankel S, Marks R, Shalom D, Nolan-Farrell M,. Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study. Br J Cancer 1996; 74: 1302-1307.
13. Karagas MR, Zens MS, Nelson HH, Mabuchi K, Perry AE, Stukel TA, et al,. Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damage. Am J Epidemiol 2007; 165: 719-726.
14. Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes Bavinck JN,. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol 2003; 120: 1087-1093.
15. DiGiovanna JJ, Kraemer KH,. Shining a light on xeroderma pigmentosum. J Invest Dermatol 2012; 132 (3 Pt 2): 785-796.
16. Schwarz T, Beissert S,. Milestones in photoimmunology. J Invest Dermatol 2013; 133: E7-E10.
17. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffell DJ,. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Investig Dermatol Symp Proc 1996; 1: 136-142.
18. Nomura T, Nakajima H, Hongyo T, Taniguchi E, Fukuda K, Li LY, et al,. Induction of cancer, actinic keratosis, and specific p53 mutations by UVB light in human skin maintained in severe combined immunodeficient mice. Cancer Res 1997; 57: 2081-2084.
19. Roewert-Huber J, Stockfleth E, Kerl H,. Pathology and pathobiology of actinic (solar) keratosis-an update. Br J Dermatol 2007; 157 (Suppl. 2): 18-20.
20. Garland CF, Garland FC, Gorham ED,. Epidemiologic evidence for different roles of ultraviolet A and B radiation in melanoma mortality rates. Ann Epidemiol 2003; 13: 395-404.
21. Wang SQ, Setlow R, Berwick M, Polsky D, Marghoob AA, Kopf AW, et al,. Ultraviolet A and melanoma: a review. J Am Acad Dermatol 2001; 44: 837-846.
22. Harwood CA, Proby CM,. Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis 2002; 15: 101-114.
23. Lebwohl MG, Rosen T, Stockfleth E,. The role of human papillomavirus in common skin conditions: current viewpoints and therapeutic options. Cutis 2010; 86: S1-S11; quiz suppl 2.
24. Queille S, Luron L, Spatz A, Avril MF, Ribrag V, Duvillard P, et al,. Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene. Carcinogenesis 2007; 28: 724-731.
25. Viarisio D, Mueller-Decker K, Kloz U, Aengeneyndt B, Kopp-Schneider A, Grone HJ, et al,. E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathog 2011; 7: e1002125.
26. Frost CA, Green AC,. Epidemiology of solar keratoses. Br J Dermatol 1994; 131: 455-464.
27. Frost CA, Green AC, Williams GM,. The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia). Br J Dermatol 1998; 139: 1033-1039.
28. Parrish JA,. Immunosuppression, skin cancer, and ultraviolet A radiation. N Engl J Med 2005; 353: 2712-2713.
29. Stockfleth E, Ulrich C, Meyer T, Christophers E,. Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res 2002; 160: 251-258.
30. Tessari G, Girolomoni G,. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management. Dermatol Surg 2012; 38: 1622-1630.
31. Ulrich C, Christophers E, Sterry W, Meyer T, Stockfleth E,. Hauterkrankungen bei organtransplantierten Patienten [Skin diseases in organ transplant patients]. Hautarzt 2002; 53: 524-533.
32. Cancer Council Australia, Australian Cancer Network. Clinical Practice Guide: Basal Cell Carcinoma, Squamous Cell Carcinoma (and Related Lesions): A Guide to Clinical Management in Australia. Cancer Council Australia, 2008. Available from: http://www.cancer.org.au/content/pdf/HealthProfessionals/ClinicalGuidelines/Basal-cell-carcinoma-Squamous-cell-carcinoma-Guide-Nov-2008-Final-with-Corrigendums.pdf, last accessed: January 12th, 2015.
33. Frost C, Williams G, Green A,. High incidence and regression rates of solar keratoses in a queensland community. J Invest Dermatol 2000; 115: 273-277.
34. Marks R, Foley P, Goodman G, Hage BH, Selwood TS,. Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol 1986; 115: 649-655.
35. Werner RN, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A,. The natural history of actinic keratosis: a systematic review. Br J Dermatol 2013; 169: 502-518.
36. Schmitt JV, Miot HA,. Actinic keratosis: a clinical and epidemiological revision. An Bras Dermatol 2012; 87: 425-434.
37. Thompson SC, Jolley D, Marks R,. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329: 1147-1151.
38. Ulrich C, Jurgensen JS, Degen A, Hackethal M, Ulrich M, Patel MJ, et al,. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 2009; 161: 78-84.
39. Darlington S, Williams G, Neale R, Frost C, Green A,. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol 2003; 139: 451-455.
40. Naylor MF, Boyd A, Smith DW, Cameron GS, Hubbard D, Neldner KH,. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol 1995; 131: 170-175.
41. Green A, Williams G, Neale R, Hart V, Leslie D, Parsons P, et al,. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999; 354: 723-729.
42. van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC,. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomark Prev 2006; 15: 2546-2548.
43. Morsy H, Kamp S, Jemec GB,. Outcomes in randomized controlled trials in psoriasis: what has changed over the last 20 years? J Dermatolog Treat 2007; 18: 261-267.
44. Werner RN, Jacobs A, Rosumeck S, Nast A,. Online consensus conferences for clinical guidelines development-A survey among participants from the International Guidelines for the Treatment of Actinic Keratosis. J Eval Clin Pract 2014; 20: 853-856.
45. Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, et al,. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013; 66: 719-725.
46. Andrews JC, Schunemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, et al,. GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol 2013; 66: 726-735.
47. Olsen EA, Abernethy ML, Kulp-Shorten C, Callen JP, Glazer SD, Huntley A, et al,. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 24 (5 Pt 1): 738-743.
48. Quaedvlieg PJ, Tirsi E, Thissen MR, Krekels GA,. Actinic keratosis: how to differentiate the good from the bad ones? Eur J Dermatol 2006; 16: 335-339.